MedPath

Evaluation of outcomes of radiotherapy in metastatic spinal cord compression in lung cancer

Not Applicable
Completed
Conditions
Health Condition 1: null- metastatic spinal cord compression in lung cancer
Registration Number
CTRI/2016/06/006981
Lead Sponsor
Tata Memorial Centre
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

•Age 18 years and above

•NSCLC/SCLC

•Presence of solitary or multiple tumour deposits/soft tissue mass/metastatic disruption of the bony cortex around the spinal cord that are extrinsically compressing the thecal sac as diagnosed on MRI or CT or evidence of clinical myeloradiculopathy with or without osteolysis evident on X-Ray and or Bone Scan in patients with progressive neoplastic disease.

•Informed consent (although have requested for waiver of consent from IEC)

Exclusion Criteria

•Surgical intervention for treatment of MSCC

•Previous irradiation in the affected region of the spine

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary objective of this study is to evaluate the various radiotherapy regimen 2 weeks, 1 month and 6 months after completion of RT, with respect to : <br/ ><br>â?¢Pain Relief <br/ ><br>â?¢Improvement in motor function/Ambulatory status <br/ ><br>â?¢Sphincter control <br/ ><br> <br/ ><br>Timepoint: NI
Secondary Outcome Measures
NameTimeMethod
To determine whether there is any difference in outcome with respect to overall survival.Timepoint: NA
© Copyright 2025. All Rights Reserved by MedPath